ClinicalTrials.gg
CompletedNCT07747038Updated Aug 5, 2026

Caudal Block v/s Local Wound Infiltration for Pain Control in Pediatric Patients After Operation for Inguinal Hernia

An interventional study of Caudal Block with Ropivacaine Intervention and Local Wound Infiltration with Ropivacaine Intervention in Postoperative Pain, sponsored by Fatima Memorial Hospital. Completed at 1 site in Pakistan. Open to participants aged 2 Years to 10 Years. Per ClinicalTrials.gov, last updated 2026-08-05.

Sponsored by Fatima Memorial Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Jul 2025, registered Jul 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
2 Years to 10 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 137 studies in Pain, Postoperative with a site in Pakistan — 41 open to participants now, 45 under way, 5 of them phase 3. Pain, Postoperative · Pakistan.

Enrollment
34th of 135
100 · median 78
Started
2025
with 28 others
No phase
86 of 137
27 open now
Registered
116th of 137
by date
Lead sponsor
6 of 137
Fatima Memorial Hospital

Among the 137 studies in Pain, Postoperative with a site in Pakistan, this one is the 34th largest by enrollment of the 135 interventional ones that give a count, is one of 29 that started in 2025, is one of 86 with no phase, and was the 116th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

41 of the 137 studies in Pain, Postoperative with a site in Pakistan are open now. Recruiting first, the newest first:

36 more — sign in →

All 41 open studies →

A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 2 Years to 10 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 137 studies in Pain, Postoperative with a site in Pakistan, or all of them as a file.
02

Study summary

This randomized controlled trial aims to compare the analgesic efficacy of local wound infiltration with Ropivacaine versus Caudal Block with Ropivacaine in pediatric patients undergoing surgery for inguinal hernia

Read the detailed description

Pediatric patients undergoing inguinal hernia surgeries experience postoperative pain. Conventional pain management methods, including opiates, may pose significant side effects. This study addresses the imperative need for optimizing postoperative pain management by systematically investigating and comparing the analgesic effects of local wound infiltration versus caudal block. The study involves 100 patients allocated into two equal groups using a lottery method: one group receiving caudal block; and other group local wound infiltration . Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.

03

Conditions studied

  • Postoperative Pain

Browse trials for

04

Who can participate

Ages eligible
2 Years to 10 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Male and female patients aged 2-10 years.
  2. Patients undergoing open elective herniotomy.
  3. Patients classified as ASA () classes I and II.

Exclusion criteria

Exclusion Criteria:

  1. Patients with recurrent, bilateral, complicated, or obstructed hernias.
  2. History of bleeding disorders.
  3. Presence of congenital anomalies of the spine.
  4. History of drug allergy.
  5. Infection at the caudal injection site.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (actual)

Study arms

  • Experimental
    Group A: Caudal Block Group

    Pediatric patients undergoing open elective inguinal herniotomy who receive a post-operative caudal block.

    Drug: Caudal Block with Ropivacaine Intervention · Drug: Intravenous Paracetamol Suspension Intervention

  • Active comparator
    Group B: Local wound infiltration

    Pediatric patients undergoing open elective inguinal herniotomy who receive post-operative local wound infiltration.

    Drug: Local Wound Infiltration with Ropivacaine Intervention · Drug: Intravenous Paracetamol Suspension Intervention

Interventions

  • DrugCaudal Block with Ropivacaine Intervention

    Administered after surgery using the landmark technique with 0.25% ropivacaine at a dose of 2mg/kg body weight.

  • DrugLocal Wound Infiltration with Ropivacaine Intervention

    Administered after surgery by pediatric surgeons using 0.5% ropivacaine at a dose of 2mg/kg body weight into the groin skin crease incision.

  • DrugIntravenous Paracetamol Suspension Intervention

    Administered as rescue analgesia at a dose of 15 ml/kg body weight if the patient's postoperative pain score reaches 3 or higher on the Hannallah Modified Objective Pain Scale.

06

What researchers measure

Primary outcomes

  1. Postoperative Analgesic Requirement

    Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.

    Time frame: Within first 8 hours after surgery

  2. Postoperative Analgesia requirement

    Post-operative pain will be assessed at 30 minutes, and 1, 2, 4, 6, and 8 hours using the Hannallah Modified Objective Pain Scale. At any stage, if a pain score of 3 or more is observed, it will be considered severe pain, and rescue analgesia in intravenous paracetamol suspension at 15 ml/kg body weight will be administered.

    Time frame: Within first 8 hours after surgery

07

Study locations

1 site
  • Department of Anesthesia, Fatima Memorial Hospital Lahore, Punjab, Pakistan, 54000
    Lahore, Punjab Province, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jul 2025 to primary completion in Jul 2026, 12 months.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's 12 months is close to that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 31, 2026
First posted
Aug 5, 2026
StartActual
Jul 1, 2025
Primary completionActual
Jul 1, 2026
CompletionActual
Jul 1, 2026
Last update
Aug 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07747038
Lead sponsor
Fatima Memorial Hospital
Responsible party
Rimsha Zafar (COMPARISON OF ANALGESIC EFFECTS OF WOUND INFILTRATION WITH ROPIVACAINE VERSUS CAUDAL BLOCK WITH ROPIVACAINE IN PEDIATRIC PATIENTS UNDERGOING INGUINAL HERNIOTOMY INTRODUCTION, Fatima Memorial Hospital) — Principal investigator
First posted
Aug 5, 2026
Start date
Jul 1, 2025
Primary completion
Jul 1, 2026
Completion
Jul 1, 2026
Last update
Aug 5, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion